(S)-benzyl 2-(2-(benzyloxycarbonylamino)acetamido)-6-((2S,3R)-3-hexyl-4-oxooxetane-2-carboxamido)hexanoate

ID: ALA4081526

PubChem CID: 137647871

Max Phase: Preclinical

Molecular Formula: C33H43N3O8

Molecular Weight: 609.72

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCC[C@H]1C(=O)O[C@@H]1C(=O)NCCCC[C@H](NC(=O)CNC(=O)OCc1ccccc1)C(=O)OCc1ccccc1

Standard InChI:  InChI=1S/C33H43N3O8/c1-2-3-4-11-18-26-29(44-31(26)39)30(38)34-20-13-12-19-27(32(40)42-22-24-14-7-5-8-15-24)36-28(37)21-35-33(41)43-23-25-16-9-6-10-17-25/h5-10,14-17,26-27,29H,2-4,11-13,18-23H2,1H3,(H,34,38)(H,35,41)(H,36,37)/t26-,27+,29+/m1/s1

Standard InChI Key:  XDCPTKKQNAGZNF-XQFUHLNNSA-N

Molfile:  

     RDKit          2D

 44 46  0  0  0  0  0  0  0  0999 V2000
   16.3718   -9.3555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6543  -11.1905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7862  -10.3837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9320   -9.9591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0726  -12.2820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0666   -9.9782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4067  -10.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5717   -9.1470    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.2164  -10.3756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5808  -10.8672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1634  -10.1555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6364   -9.9862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8985  -12.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3632   -9.9471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6551  -11.5704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6516  -10.3645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0834   -8.9379    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.4978   -9.9662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3550  -10.3957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8281  -11.5772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3601  -11.2188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6499  -11.6348    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0756  -11.6258    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0807  -12.4489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3705  -12.8649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6593  -12.4541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9495  -12.8694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9542  -13.6934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6747  -14.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3815  -13.6825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9259  -10.4018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2108   -9.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9306  -11.2249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5002  -10.4099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7851  -10.0023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0747  -10.4179    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7805   -9.1792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3594  -10.0104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6490  -10.4260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9384  -10.0163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2284  -10.4312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2327  -11.2553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9528  -11.6626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6599  -11.2453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 16  4  1  0
  9 18  1  0
 10  7  1  0
  1 17  2  0
  3  6  1  0
  6 19  1  0
 20 15  1  0
  4  9  1  0
 18  3  1  0
 11  1  1  0
 15  5  1  0
  7 20  1  0
 19 12  1  0
 14 16  1  1
 11 10  1  6
  5 13  1  0
 16  2  2  0
 14 11  1  0
  8 14  1  0
  1  8  1  0
 19 21  1  1
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 12 31  1  0
 31 32  1  0
 31 33  2  0
 32 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4081526

    ---

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB2 Tclin Proteasome Macropain subunit (1025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB1 Tclin Proteasome component C5 (935 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB5 Tclin Proteasome Macropain subunit MB1 (2451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 609.72Molecular Weight (Monoisotopic): 609.3050AlogP: 3.94#Rotatable Bonds: 19
Polar Surface Area: 149.13Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.08CX Basic pKa: CX LogP: 4.58CX LogD: 4.58
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.12Np Likeness Score: -0.04

References

1. Zhu M, Harshbarger WD, Robles O, Krysiak J, Hull KG, Cho SW, Richardson RD, Yang Y, Garcia A, Spiegelman L, Ramirez B, Wilson CT, Yau JA, Moore JT, Walker CB, Sacchettini JC, Liu WR, Sieber SA, Smith JW, Romo D..  (2017)  A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.,  25  (11): [PMID:28236510] [10.1016/j.bmc.2017.01.020]

Source